CD123 as a Therapeutic Target Against Malignant Stem Cells

This publication has 89 references indexed in Scilit:

• T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
  Blood, 2013
• Signatures of mutational processes in human cancer
  Nature, 2013
• Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
  New England Journal of Medicine, 2013
• The Origin and Evolution of Mutations in Acute Myeloid Leukemia
  Cell, 2012
• Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells
  Science Translational Medicine, 2010
• CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
  Cell, 2009
• CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
  Cell, 2009
• Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord Blood
  Cell Stem Cell, 2007
• CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia
  Proceedings of the National Academy of Sciences, 2007
• Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
  Nature Medicine, 1997